Welcome to our dedicated page for Precision Optics SEC filings (Ticker: POCI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Precision Optics Corporation, Inc. filings document the regulatory record for a Nasdaq-listed manufacturer of advanced optical instruments and custom optical assemblies. The company’s disclosures identify its common stock, material agreements and capital-structure activity, including underwriting arrangements connected with equity issuance.
Proxy and current-report filings for POCI cover annual meeting votes, director elections, advisory compensation matters, corporate governance, director and executive compensation, beneficial ownership, equity compensation plan information and related-person transaction disclosure. The filing record also provides formal documentation of shareholder voting matters and other material events reported under the Exchange Act.
Precision Optics Corporation files Amendment No. 3 to a Schedule 13G/A disclosing that Needham Investment Management L.L.C., Needham Asset Management, LLC, Needham Aggressive Growth Fund and George A. Needham each report beneficial ownership of 1,670,550 shares, equal to 15.3% of the class as of 03/31/2026.
The filing states these shares are held for advisory clients of Needham Investment Management L.L.C., with shared voting and shared dispositive power reported. Exhibits include a Joint Filing Agreement and control-person identification; signatures bear a 05/15/2026 execution date.
Precision Optics Corporation reported sharply higher results for the quarter ended March 31, 2026, driven by strong systems manufacturing demand and a recent equity raise. Quarterly revenue rose to $8.7 million from $4.2 million, while the net loss narrowed to $108,283 from $2.1 million. For the first nine months, revenue grew to $22.8 million from $12.9 million and the net loss improved to $3.5 million from $4.4 million. Gross margin increased to 23.6% in the quarter, helped by operating leverage and $224,544 of grant income, though full-year gross margin is lower due to earlier mix and ramp costs. The company strengthened its balance sheet with a March 2026 public offering that raised net proceeds of $10.6 million, boosting cash to $10.7 million and stockholders’ equity to $20.1 million. Management notes ongoing debt service coverage covenant waivers through fiscal 2025 and is discussing longer-term solutions with its lender while stating current liquidity is sufficient to repay outstanding term loans if required.
PRECISION OPTICS CORPORATION, INC. insider filings show that Needham Aggressive Growth Fund holds 1,670,550 shares of common stock. These shares may be deemed indirectly beneficially owned by Needham Investment Management LLC and George A. Needham, who both disclaim beneficial ownership beyond their pecuniary interests. The Form 3 reflects existing holdings rather than a new purchase or sale.
Needham Aggressive Growth Fund, an investment advisory client of Needham Investment Management LLC, reported ownership of 1,670,550 shares of Precision Optics Corporation common stock as of March 27, 2026. The shares may be deemed indirectly beneficially owned by Needham Investment Management LLC and its President and CEO, George A. Needham, who each disclaim beneficial ownership beyond their pecuniary interests.
COLL WAYNE M reported acquisition or exercise transactions in this Form 4 filing.
PRECISION OPTICS CORPORATION, INC. Chief Financial Officer Wayne M. Coll received a grant of 1,568 shares of common stock on March 31, 2026 as compensation. The shares were issued under an Employment Agreement that allows up to $25,000 per year of salary to be paid in stock.
The stock was priced at a quarterly volume weighted average price of $3.985 for the quarter ended March 31, 2026, based on payroll withholdings. After this grant, Coll directly owns 36,807 shares of Precision Optics common stock.
PRECISION OPTICS CORPORATION, INC. Chief Financial Officer Wayne M. Coll reported an open-market purchase of the company’s Common Stock. On March 30, 2026, he bought 20,833 shares at a price of $3.60 per share in an underwritten public offering. Following this transaction, he directly owns 35,239 shares of Precision Optics common stock.
Precision Optics Corporation, Inc. CEO Joseph Norman Forkey bought 1,388 shares of common stock in an open-market purchase. The transaction was completed at $3.60 per share in connection with an underwritten public offering. Following this purchase, he directly holds 143,959 common shares.
PRECISION OPTICS CORPORATION, INC. Chief Operating Officer Joseph Traut bought 41,666 shares of Common Stock at $3.60 per share in an underwritten public offering. This open-market purchase increased his directly held stake to 41,666 shares.
The transaction was reported as a standard open-market purchase, with each share acquired at the public offering price set for the underwritten deal.
Precision Optics Corporation, Inc. shareholders Norman, Sandra, and Brian Pessin report their updated ownership on an amended Schedule 13D. Norman H. Pessin holds 429,247 common shares, or 3.9% of the company. Sandra F. Pessin holds 477,361 shares, or 4.4%, and Brian L. Pessin holds 550,673 shares, or 5.0%.
Their shares were acquired with personal funds for a total purchase cost of about $1.65 million for Norman, $1.40 million for Sandra, and $1.87 million for Brian, including commissions. They originally bought the stock believing it was undervalued and state they may buy more, sell shares, communicate with management and the board, propose changes to capitalization or operations, or use hedging and short-selling strategies depending on market conditions and the company’s situation. Recent transactions in the past sixty days were effected through a prospectus supplement offering dated March 30, 2026.
Precision Optics Corporation, Inc. entered into an underwriting agreement with Lucid Capital Markets for an underwritten public offering of 2,777,777 shares of common stock at $3.60 per share. The company also granted a 45-day over-allotment option for up to 416,667 additional shares at the same public offering price, less the underwriting discount.
The company expects net proceeds of approximately $10.7 million, assuming full exercise of the over-allotment option, after underwriting discounts, commissions and expenses. It plans to use the proceeds for working capital and general corporate purposes. The offering, made off an effective Form S-3 shelf registration, closed on March 30, 2026.
In connection with the deal, the underwriter received a discount of up to 6.5% of gross proceeds, reimbursement of certain expenses up to $90,000, and Representative’s Warrants to purchase up to 159,722 shares at an exercise price of $4.21 per share, exercisable from March 30, 2026 until March 27, 2031.